AKT1 and hepatocellular carcinoma: As mentioned earlier, overexpressed FGFR1 together with activated AKT/mTOR and ERK pathways could induce LR in HCC, and oxysophocarpine could reduce the expression of FGFR1 and concurrently suppress the downstream signaling, thereby enhancing the sensitivity of lenvatinib 26.